Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Vincent

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Journal of Clinical Investigation|May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulationRebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
Nature Communications|July 19, 2023
SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing SarcomaConnor J Hughes, Kaiah M Fields, Etienne P Danis, et al.
Dalton Transactions (Cambridge, England : 2003)|February 6, 2020
Anti-inflammatory activity of superoxide dismutase mimics functionalized with cell-penetrating peptidesEmilie Mathieu, Anne-Sophie Bernard, H Y Vincent Ching, et al.
Journal of the American Chemical Society|July 24, 2023
An Atomically Dispersed Mn-Photocatalyst for Generating Hydrogen Peroxide from Seawater via the Water Oxidation Reaction (WOR)Peng Ren, Tong Zhang, Noopur Jain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2017
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T CellsLynsey M Whilding, Ana C Parente-Pereira, Tomasz Zabinski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T CellsLynsey M Whilding, Ana C Parente-Pereira, Tomasz Zabinski, et al.
Journal of Inorganic Biochemistry|November 12, 2022
GLB-3: A resilient, cysteine-rich, membrane-tethered globin expressed in the reproductive and nervous system of Caenorhabditis elegansZainab Hafideddine, Tim Loier, Niels Van Brempt, et al.
Communications Medicine|May 21, 2024
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumorsJian Jenny Chen, Melanie Y Vincent, Dale Shepard, et al.
Neuro-Oncology|July 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progressionArthur R Wolin, Melanie Y Vincent, Taylor Hotz, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Clinical Investigation|May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulationRebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
Nature Communications|July 19, 2023
SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing SarcomaConnor J Hughes, Kaiah M Fields, Etienne P Danis, et al.
Dalton Transactions (Cambridge, England : 2003)|February 6, 2020
Anti-inflammatory activity of superoxide dismutase mimics functionalized with cell-penetrating peptidesEmilie Mathieu, Anne-Sophie Bernard, H Y Vincent Ching, et al.
Journal of the American Chemical Society|July 24, 2023
An Atomically Dispersed Mn-Photocatalyst for Generating Hydrogen Peroxide from Seawater via the Water Oxidation Reaction (WOR)Peng Ren, Tong Zhang, Noopur Jain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2017
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T CellsLynsey M Whilding, Ana C Parente-Pereira, Tomasz Zabinski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T CellsLynsey M Whilding, Ana C Parente-Pereira, Tomasz Zabinski, et al.
Journal of Inorganic Biochemistry|November 12, 2022
GLB-3: A resilient, cysteine-rich, membrane-tethered globin expressed in the reproductive and nervous system of Caenorhabditis elegansZainab Hafideddine, Tim Loier, Niels Van Brempt, et al.
Communications Medicine|May 21, 2024
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumorsJian Jenny Chen, Melanie Y Vincent, Dale Shepard, et al.
Neuro-Oncology|July 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progressionArthur R Wolin, Melanie Y Vincent, Taylor Hotz, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Pageof 7